Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly prescribed to the growing number of cancer patients (more than two million in the UK alone) often to treat hypertension. However, increased fatal cancer in ARB users in a randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardwell, Chris R, Mc Menamin, Úna C, Hicks, Blánaid M, Hughes, Carmel, Cantwell, Marie M, Murray, Liam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926686/
https://www.ncbi.nlm.nih.gov/pubmed/24521426
http://dx.doi.org/10.1186/1741-7015-12-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926686/
https://www.ncbi.nlm.nih.gov/pubmed/24521426
http://dx.doi.org/10.1186/1741-7015-12-28

Ejemplares similares